The Full Story
MYOPIA MANAGEMENT
We offer Myopia Management preventative care as early as 5 years old, and now also offer MiSight® 1 day contact lens (the only FDA approved*soft contact lens indicated to slow the progression of myopia in children ages 8-12 years old at the initiation of treatment
What is MiSight?
MiSight ® 1 Day is a daily wear, single use contact lens that has been clinically proven and FDA- approved to slow the progression of myopia (nearsightedness).
The treatment helps slow the elongation of the eye and myopia progression, while fullycorrecting refractive error.
​
Addressing axial elongation helps to reduce the risk of myopia-related vision complications later in life, including irreversible vision loss.
Safety and Effectiveness of
MiSight Contact Lenses
​
The safety and effectiveness of MiSight were studied in a 3-year clinical trial of 135 children aged 8 to 12 who were prescribed either MiSight or traditional soft contact lenses.
​
Over the 3-year period, myopia progressed at a much slower rate — by 59% to be exact — in the children who wore MiSight contact lenses compared to the children who wore conventional soft contacts.
​
These results indicate that MiSight could be an excellent option for slowing myopia progression in your child.
​
Speak with Our Myopia Management Experts to learn more about MiSight contact lenses and to find out how they can help your child effectively limit myopia progression.
